Cargando…
Decreased response inhibition in middle-aged male patients with type 2 diabetes
BACKGROUND: This study was performed to examine whether patients with type 2 diabetes have cognitive deficits associated with the prefrontal cortex (PFC). METHODS: Twenty-seven middle-aged patients with newly diagnosed type 2 diabetes and 27 healthy controls underwent physical measurements and neuro...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834594/ https://www.ncbi.nlm.nih.gov/pubmed/20181219 http://dx.doi.org/10.1186/1751-0759-4-1 |
_version_ | 1782178575644884992 |
---|---|
author | Ishizawa, Kaya T Kumano, Hiroaki Sato, Atsushi Sakura, Hiroshi Iwamoto, Yasuhiko |
author_facet | Ishizawa, Kaya T Kumano, Hiroaki Sato, Atsushi Sakura, Hiroshi Iwamoto, Yasuhiko |
author_sort | Ishizawa, Kaya T |
collection | PubMed |
description | BACKGROUND: This study was performed to examine whether patients with type 2 diabetes have cognitive deficits associated with the prefrontal cortex (PFC). METHODS: Twenty-seven middle-aged patients with newly diagnosed type 2 diabetes and 27 healthy controls underwent physical measurements and neuropsychological tasks. Response inhibition, reward prediction, and executive function were assessed by the Go/NoGo task, the reversal and extinction tasks, and the Wisconsin Card Sorting Test (WCST). To examine the interactions of being overweight with diabetes on cognitive performance, performance data were analysed by two-way ANCOVA with diabetes and overweight as factors and age as a covariate. RESULTS: Patients with type 2 diabetes showed significantly decreased response inhibition in the Go/NoGo task (discriminability index: P = 0.001). There was an interaction of being overweight with diabetes on reaction time in the Go trials of the Go/NoGo task (P = 0.009). Being overweight was related to retained responses to the presentiment of reward in the extinction task (P = 0.029). The four groups showed normal cognitive performance in the WCST. CONCLUSIONS: Our results showed that middle-aged, newly diagnosed and medication-free patients with type 2 diabetes have a particular neuropsychological deficit in inhibitory control of impulsive response, which is an independent effect of diabetes apart from being overweight. |
format | Text |
id | pubmed-2834594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28345942010-03-09 Decreased response inhibition in middle-aged male patients with type 2 diabetes Ishizawa, Kaya T Kumano, Hiroaki Sato, Atsushi Sakura, Hiroshi Iwamoto, Yasuhiko Biopsychosoc Med Research BACKGROUND: This study was performed to examine whether patients with type 2 diabetes have cognitive deficits associated with the prefrontal cortex (PFC). METHODS: Twenty-seven middle-aged patients with newly diagnosed type 2 diabetes and 27 healthy controls underwent physical measurements and neuropsychological tasks. Response inhibition, reward prediction, and executive function were assessed by the Go/NoGo task, the reversal and extinction tasks, and the Wisconsin Card Sorting Test (WCST). To examine the interactions of being overweight with diabetes on cognitive performance, performance data were analysed by two-way ANCOVA with diabetes and overweight as factors and age as a covariate. RESULTS: Patients with type 2 diabetes showed significantly decreased response inhibition in the Go/NoGo task (discriminability index: P = 0.001). There was an interaction of being overweight with diabetes on reaction time in the Go trials of the Go/NoGo task (P = 0.009). Being overweight was related to retained responses to the presentiment of reward in the extinction task (P = 0.029). The four groups showed normal cognitive performance in the WCST. CONCLUSIONS: Our results showed that middle-aged, newly diagnosed and medication-free patients with type 2 diabetes have a particular neuropsychological deficit in inhibitory control of impulsive response, which is an independent effect of diabetes apart from being overweight. BioMed Central 2010-02-11 /pmc/articles/PMC2834594/ /pubmed/20181219 http://dx.doi.org/10.1186/1751-0759-4-1 Text en Copyright ©2010 Ishizawa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Ishizawa, Kaya T Kumano, Hiroaki Sato, Atsushi Sakura, Hiroshi Iwamoto, Yasuhiko Decreased response inhibition in middle-aged male patients with type 2 diabetes |
title | Decreased response inhibition in middle-aged male patients with type 2 diabetes |
title_full | Decreased response inhibition in middle-aged male patients with type 2 diabetes |
title_fullStr | Decreased response inhibition in middle-aged male patients with type 2 diabetes |
title_full_unstemmed | Decreased response inhibition in middle-aged male patients with type 2 diabetes |
title_short | Decreased response inhibition in middle-aged male patients with type 2 diabetes |
title_sort | decreased response inhibition in middle-aged male patients with type 2 diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834594/ https://www.ncbi.nlm.nih.gov/pubmed/20181219 http://dx.doi.org/10.1186/1751-0759-4-1 |
work_keys_str_mv | AT ishizawakayat decreasedresponseinhibitioninmiddleagedmalepatientswithtype2diabetes AT kumanohiroaki decreasedresponseinhibitioninmiddleagedmalepatientswithtype2diabetes AT satoatsushi decreasedresponseinhibitioninmiddleagedmalepatientswithtype2diabetes AT sakurahiroshi decreasedresponseinhibitioninmiddleagedmalepatientswithtype2diabetes AT iwamotoyasuhiko decreasedresponseinhibitioninmiddleagedmalepatientswithtype2diabetes |